Skip to main content
Ovarian Cancer
NeoPembrOV Study of Neoadjuvant Chemotherapy with or without Pembrolizumab Followed by Interval Debulking Surgery and Standard Systemic Therapy with or without Pembrolizumab for Advanced High-Grade Serous Carcinoma
Read More
Ovarian Cancer
Optimal Treatment Duration of Bevacizumab plus Carboplatin/Paclitaxel in Advanced Ovarian Cancer
Read More
Ovarian Cancer
Phase 1 Study of GAS6/AXL Inhibitor (AVB-500) in Recurrent, Platinum-Resistant Ovarian Carcinoma
Read More
Ovarian Cancer
Anlotinib in Combination with TQB2450 in Patients with Recurrent Ovarian Cancer (ACTION)
Read More
Ovarian Cancer
Niraparib Efficacy and Safety in Patients with BRCA-Mutated Ovarian Cancer from 3 Phase 3 Trials
Read More
Ovarian Cancer
Real-World Treatment Patterns of Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer
Read More
Ovarian Cancer
Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal
Read More
Ovarian Cancer, PARP Inhibitors
Immunologic Response to COVID-19 Vaccination in Patients with Ovarian Cancer Receiving PARP Inhibitors
Read More
Ovarian Cancer
Intervention of a Health Education Clinical Nursing Pathway Among Patients with Ovarian Carcinoma
Read More
Ovarian Cancer
Implementation of a Collaborative Model Provides Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer
Read More
Page 69 of 199
Results 681 - 690 of 1986